Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1903)
LEMAITRE VASCULAR INC (LMAT)
Kamke Trent G — Senior V. P., Operations
Shares
2,928
Price
$107.00
Total Value
$313.29K
Shares Held After
3,749
% of Holdings
43.9%
Avantor, Inc. (AVTR)
LUCIER GREGORY T — Director
Shares
10,000
Price
$8.32
Total Value
$83.20K
Shares Held After
60,000
% of Holdings
16.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$571.66
Total Value
$297.27K
Shares Held After
40,513
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$570.22
Total Value
$282.26K
Shares Held After
41,033
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$569.61
Total Value
$60.38K
Shares Held After
41,528
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.16
Total Value
$204.54K
Shares Held After
41,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$567.21
Total Value
$180.94K
Shares Held After
41,994
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
705
Price
$565.99
Total Value
$399.02K
Shares Held After
42,313
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,983
Price
$564.77
Total Value
$1.12M
Shares Held After
43,018
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,864
Price
$564.00
Total Value
$1.05M
Shares Held After
45,001
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$563.06
Total Value
$1.14M
Shares Held After
46,865
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,126
Price
$562.08
Total Value
$632.91K
Shares Held After
48,887
% of Holdings
2.3%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
15,003
Price
$38.30
Total Value
$574.61K
Shares Held After
14,769
% of Holdings
50.4%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
55,000
Price
$38.38
Total Value
$2.11M
Shares Held After
14,769
% of Holdings
78.8%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
134,985
% of Holdings
6.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
19,269
Price
$75.35
Total Value
$1.45M
Shares Held After
88,606
% of Holdings
17.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
24,814
Price
$74.76
Total Value
$1.86M
Shares Held After
107,875
% of Holdings
18.7%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
33,513
Price
$73.72
Total Value
$2.47M
Shares Held After
132,689
% of Holdings
20.2%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,404
Price
$72.57
Total Value
$174.46K
Shares Held After
166,202
% of Holdings
1.4%
908 Devices Inc. (MASS)
AWM Investment Company, Inc. — 10% Owner
Shares
3,025
Price
$8.20
Total Value
$24.80K
Shares Held After
5,121,715
% of Holdings
0.1%
CHEMED CORP (CHE)
GRACE PATRICK P — Director
Shares
60
Price
$425.78
Total Value
$25.55K
Shares Held After
3,337
% of Holdings
1.8%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
117
Price
$29.10
Total Value
$3.40K
Shares Held After
346,059
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
4,321
Price
$28.52
Total Value
$123.23K
Shares Held After
346,176
% of Holdings
1.2%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
721
Price
$28.28
Total Value
$20.39K
Shares Held After
242,729
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,220
Price
$29.15
Total Value
$152.16K
Shares Held After
1,560,720
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
14,880
Price
$28.47
Total Value
$423.63K
Shares Held After
1,565,940
% of Holdings
0.9%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
12,000
Price
$100.07
Total Value
$1.20M
Shares Held After
6,000
% of Holdings
66.7%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
36,000
Price
$100.14
Total Value
$3.61M
Shares Held After
27,825
% of Holdings
56.4%
Cellectar Biosciences, Inc. (CLRB)
CARUSO JAMES V — Director
Shares
8,680
Price
$2.88
Total Value
$25.00K
Shares Held After
20,318
% of Holdings
42.7%
Cellectar Biosciences, Inc. (CLRB)
Longcor Jarrod — Chief Operating Officer
Shares
8,680
Price
$2.88
Total Value
$25.00K
Shares Held After
20,451
% of Holdings
42.4%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Chaudhuri Sarbani — Chief Commercial & Medical Affairs Officer
Shares
17,650
Price
$3.84
Total Value
$67.74K
Shares Held After
267,510
% of Holdings
6.2%
Atara Biotherapeutics, Inc. (ATRA)
Panacea Innovation Ltd — 10% Owner
Shares
313,446
Price
$10.10
Total Value
$3.17M
Shares Held After
1,011,000
% of Holdings
23.7%
LEMAITRE VASCULAR INC (LMAT)
LeMaitre George W — Director
Shares
18,600
Price
$107.64
Total Value
$2.00M
Shares Held After
1,457,900
% of Holdings
1.3%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
48,546
Price
$44.61
Total Value
$2.17M
Shares Held After
2,916,228
% of Holdings
1.6%
Alphatec Holdings, Inc. (ATEC)
Valentine Keith — Director
Shares
56,153
Price
$7.49
Total Value
$420.59K
Shares Held After
153,424
% of Holdings
36.6%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
48,546
Price
$44.61
Total Value
$2.17M
Shares Held After
2,916,228
% of Holdings
1.6%
DAVITA INC. (DVA)
ACKERMAN JOEL — CFO and Treasurer
Shares
51,471
Price
$192.10
Total Value
$9.89M
Shares Held After
132,434
% of Holdings
28.0%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
18,606
Price
$24.12
Total Value
$448.82K
Shares Held After
423
% of Holdings
97.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
41
Price
$22.59
Total Value
$925.99
Shares Held After
2,224
% of Holdings
1.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
41
Price
$22.59
Total Value
$925.99
Shares Held After
2,224
% of Holdings
1.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
41
Price
$22.59
Total Value
$925.99
Shares Held After
2,224
% of Holdings
1.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
41
Price
$22.59
Total Value
$925.99
Shares Held After
2,224
% of Holdings
1.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
168
Price
$22.59
Total Value
$3.79K
Shares Held After
39,214
% of Holdings
0.4%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
198
Price
$22.59
Total Value
$4.47K
Shares Held After
46,138
% of Holdings
0.4%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
906
Price
$22.59
Total Value
$20.46K
Shares Held After
21,479
% of Holdings
4.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
237
Price
$22.08
Total Value
$5.23K
Shares Held After
2,265
% of Holdings
9.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
237
Price
$22.08
Total Value
$5.23K
Shares Held After
2,265
% of Holdings
9.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
237
Price
$22.08
Total Value
$5.23K
Shares Held After
2,265
% of Holdings
9.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
237
Price
$22.08
Total Value
$5.23K
Shares Held After
2,265
% of Holdings
9.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
985
Price
$22.08
Total Value
$21.75K
Shares Held After
39,382
% of Holdings
2.4%
Showing 851–900 of 1903 transactions (page 18 of 39)